Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
Journal of Biomedicine and Biotechnology2012Vol. 2012, pp. 1–6
Citations Over TimeTop 10% of 2012 papers
Abstract
Our data offer the convinced evidence that the increased expression of miR-17 may have potential value for predicting poor prognosis in glioma patients with high pathological grades, indicating that miR-17 may contribute to glioma progression and be a candidate therapeutic target for this disease.
Related Papers
- → LncRNA LINC01094 contributes to glioma progression by modulating miR-224-5p/CHSY1 axis(2021)19 cited
- → MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.(2018)25 cited
- → Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients(2018)7 cited
- → A dynamical model of combination therapy applied to glioma(2022)2 cited
- → CPLX2 is a novel tumor suppressor and improves the prognosis in glioma(2023)